The μ-and δ-opioid pharmacophore conformations of cyclic β-casomorphin analogues indicate docking of the Phe3 residue to different domains of the opioid receptors

No abstract is available for this paper.

• Publication year

  1996

• Venue

  J. Comput. Aided Mol. Des.

• Publication date

  1996-06-01

• Fields of study

  Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.1007/BF00355043PMID 8808737
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Conformational features responsible for the binding of cyclic analogues of enkephalin to opioid receptors. II. Models of mu- and delta-receptor-bound structures for analogues containing Phe4.

  2009cited by this paper
• Conformational analysis of enkephalin analogs containing a disulfide bond. Models for delta- and mu-receptor opioid agonists.

  2009cited by this paper
• Conformational analysis of mu-selective [D-Ala2,MePhe4]enkephalins.

  2009cited by this paper
• Structure-activity relationships of dermorphin analogues containing N-substituted amino acids in the 2-position of the peptide sequence.

  2009cited by this paper
• Proton NMR Conformational Analysis of Cyclic β‐Casomorphin Analogues of the Type Tyr‐cyclo[‐Nω‐D‐Orn‐Xaa‐Yaa‐Gly‐]

  1996cited by this paper
• Proton NMR conformational analysis of cyclic beta-casomorphin analogues of the type Tyr-cyclo[N omega-D-Orn-Xaa-Yaa-Gly-].

  1996cited by this paper
• The solution conformation of cyclic β-casomorphin-5 analogues

  1996cited by this paper
• The μ Opioid Receptor Binding Pharmacophore Conformation of Ornithine Containing Cyclic β‐Casomorphin Analogues and Related Peptides

  1995cited by this paper
• Development of a model for the delta opioid receptor pharmacophore. 1. Conformationally restricted Tyr1 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).

  1994cited by this paper
• Probes for narcotic receptor mediated phenomena. 19. Synthesis of (+)-4-[(alpha R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3- methoxybenzyl]-N,N-diethylbenzamide (SNC 80): a highly selective, nonpeptide delta opioid receptor agonist.

  1994cited by this paper
• Cyclic beta-casomorphin analogues with mixed mu agonist/delta antagonist properties: synthesis, pharmacological characterization, and conformational aspects.

  1994cited by this paper
• Synthesis of naltrexone-derived delta-opioid antagonists. Role of conformation of the delta address moiety.

  1994cited by this paper
• Development of a model for the delta opioid receptor pharmacophore. 2. Conformationally restricted Phe3 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).

  1994cited by this paper
• A selective delta 1 opioid receptor agonist derived from oxymorphone. Evidence for separate recognition sites for delta 1 opioid receptor agonists and antagonists.

  1993cited by this paper
• Characterization of the bioactive form and molecular determinants of recognition of cyclic enkephalin peptides at the δ‐opioid receptor

  1993cited by this paper
• Characterization of the bioactive form and molecular determinants of recognition of cyclic enkephalin peptides at the delta-opioid receptor.

  1993cited by this paper
• A single residue, aspartic acid 95, in the delta opioid receptor specifies selective high affinity agonist binding.

  1993cited by this paper
• A new consistent model explaining structure (conformation)-activity relationships of opiates with mu-selectivity.

  1993cited by this paper
• Linear and cyclic β-casomorphin analogues with high analgesic activity

  1992cited by this paper
• Linear and cyclic beta-casomorphin analogues with high analgesic activity.

  1992cited by this paper
• Structure-activity relationships of cyclic -casomorphin-5 analogues

  1991cited by this paper
• Function of negative charge in the "address domain" of deltorphins.

  1991cited by this paper
• Development of a conformational search strategy for flexible ligands: A study of the potent μ-selective opioid analgesic fentanyl

  1991cited by this paper
• Structure-activity relationships of cyclic beta-casomorphin-5 analogues.

  1991cited by this paper
• HAMOG: molecular graphics program for chemistry, biochemistry, molecular biology and enzyme research.

  1991cited by this paper
• Structure-activity relationships of the δ-opioid-selective agonists, deltorphins

  1991cited by this paper
• Structure-activity relationships of the delta-opioid-selective agonists, deltorphins.

  1991cited by this paper
• Structure-activity studies of novel casomorphin analogues: binding profiles towards mu 1-, mu 2- and delta -opioid receptors.

  1991cited by this paper
• Examination of the conformational meaning of “δ-address” in the dermenkephalin sequence

  1990cited by this paper
• Examination of the conformational meaning of "delta-address" in the dermenkephalin sequence.

  1990cited by this paper
• Validation of the general purpose tripos 5.2 force field

  1989cited by this paper
• Conformational determinants of high affinity delta receptor binding of opioid peptides.

  1988cited by this paper
• Molecular mechanism of opioid receptor selection.

  1986cited by this paper
• Proposals for the mu-active conformation of the enkephalin analog Tyr-cyclol(-N gamma-D-A2-bu-Gly-Phe-Leu-).

  1986cited by this paper
• Opiate receptor binding affinities of some D-amino acid substituted β-casomorphin analogs

  1986cited by this paper
• Opiate receptor binding affinities of some D-amino acid substituted beta-casomorphin analogs.

  1986cited by this paper
• Berechnung der Ladungsverteilung in konjugierten Systemen durch eine Quantifizierung des Mesomeriekonzeptes

  1985cited by this paper
• Potent morphiceptin analogs: structure activity relationships and morphine-like activities.

  1983cited by this paper
• Antinociceptive potencies of beta-casomorphin analogs as compared to their affinities towards mu and delta opiate receptor sites in brain and periphery.

  1982cited by this paper
• Antinociceptive potencies of β-casomorphin analogs as compared to their affinities towards μ and δ opiate receptor sites in brain and periphery

  1982cited by this paper
• ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES

  1980cited by this paper
• Novel opioid peptides derived from casein (beta-casomorphins). I. Isolation from bovine casein peptone.

  1979cited by this paper
• Novel opioid peptides derived from casein (beta-casomorphins). II. Structure of active components from bovine casein peptone.

  1979cited by this paper

• Chemoinformatic analysis of biologically active macrocycles.

  2010cites this paper
• Structure-activity relationship, conformation and pharmacology studies of morphiceptin analogues--selective mu-opioid receptor ligands.

  2002cites this paper
• Struktur‐ Wirkungsbeziehungen von Opioiden: Agonist oder Antagonist?

  2002cites this paper
• [Agonist or antagonist? Structure-activity relationships of opioids].

  2002cites this paper
• Beta-casomorphins: substitution of phenylalanine with beta-homo phenylalanine increases the mu-type opioid receptor affinity.

  2000cites this paper
• β-Casomorphins: substitution of phenylalanine with β-homo phenylalanine increases the μ-type opioid receptor affinity

  2000cites this paper
• A molecular mechanism for the cleavage of a disulfide bond as the primary function of agonist binding to G-protein-coupled receptors based on theoretical calculations supported by experiments.

  1999cites this paper
• Amino acids and peptides. LII. Design and synthesis of opioid mimetics containing a pyrazinone ring and examination of their opioid receptor binding activity.

  1998cites this paper
• High Performance Liquid Chromatography on Calixarene-Bonded Silica Gels. III. Separations of cis/trans Isomers of Proline-Containing Peptides

  1998cites this paper
• A uniform molecular model of delta opioid agonist and antagonist pharmacophore conformations.

  1998cites this paper
• [Opioid agonists and antagonists, opioid receptors].

  1997cites this paper
• Opioid Diketopiperazines: Synthesis and Activity of a Prototypic Class of Opioid Antagonists

  1997cites this paper